Aim: To investigate the α 1B -adrenoceptor (α 1B -AR)-mediated cAMP response and underlying mechanisms in HEK293 cells. Methods: Full-length cDNA encoding α 1B -AR was transfected into HEK293 cells using the calcium phosphate precipitation method, and α 1B -AR expression and cAMP accumulation were determined by using the saturation radioligand binding assay and ion-exchange chromatography, respectively. Results: Under agonist stimulation, α 1B -AR mediated cAMP synthesis in HEK293 cells, and blockade by PLC-PKC or tyrosine kinase did not reduce cAMP accumulation induced by NE. Pretreatment with pertussis toxin (PTX) had little effect on basal cAMP accumulation as well as norepinephrine (NE)-stimulated cAMP accumulation. In addition, pretreatment with cholera toxin (CTX) neither mimicked nor blocked the effect induced by NE. The extracellular Ca 2+ chelator egtazic acid (EGTA), nonselective Ca 2+ channel blocker CdCl 2 and calmodulin (CaM) inhibitor W-7 significantly reduced NE-induced cAMP accumulation from 1.59%±0.47% to 1.00%±0.31%, 0.78%±0.23%, and 0.90%±0.40%, respectively. Conclusion: By coupling with a PTX-insensitive G protein, α 1B -AR promotes Ca 2+ influx via receptor-dependent Ca 2+ channels, then Ca 2+ is linked to CaM to form a Ca 2+ -CaM complex, which stimulates adenylyl cyclase (AC), thereby increasing the cAMP production in HEK293 cell lines.
Introduction
It is well known that the classic signaling pathway of α 1 -adrenoceptor (AR) is to couple with the G q/11 protein and then stimulate phosphatidylinositol turnover [1, 2] . However, it has been recently discovered that α 1 -AR can also stimulate adenosine 3':5'-cyclic monophosphate (cAMP) accumulation in several cell lines, tissues and organs [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Our previous study showed that each of the three α 1 -AR subtypes was able to mediate cAMP generation in human embryonic kidney 293 (HEK293) cells. As for the signal transduction pathway by which α 1 -AR mediates cAMP production, several studies have shown that cAMP production is secondary to the α 1 -AR-induced phospholipase C (PLC)-phosphokinase C (PKC) stimulation [10] [11] [12] , which cross-talked with AC [13] . Horie et al [14] found that in a Chinese hamster ovary (CHO) cell line transfected with α 1B -AR, none of the PKC inhibitor, the Ca 2+ ionophore, or the pertussis toxin (PTX) was able to inhibit NE-induced cAMP accumulation, whereas anti-G sα antiserum inhibited the response, which suggests that α 1B -AR activates AC and increases intracellular cAMP by directly coupling with G sα . In fact the signal transduction pathway involved in α 1B -AR-mediated cAMP generation remains unclear. Therefore, we transfected HEK293 cells (human embryonic kidney 293 cell line, which does not express any other adrenoceptors except native β 2 -AR) with full-length cDNA encoding α 1B -AR and selected for subcloning cell lines stably expressing α 1B -AR. This was a good model to investigate the regulating effects of the PLC-PKC pathway, the tyrosine kinase pathway, the Ca 2+ signal system, and G proteins on cAMP production.
Materials and methods
Norepinephrine (NE), phenylephrine (PE), methoxamine (ME), prazosin (PRZ), propranolol (Prop), Triton X-100, cAMP, 3-isobutyl-1-methyl-xanthine (IBMX), pyruvic acid, hygromycin B, cyclopiazonic acid (CPA), phorbol 12-myristate 13-acetate (PMA), genistein, tyrphostin A25, egtazic acid (EGTA), nifedipine (Nif), CdCl 2 , PTX, and cholera toxin (CTX) were from Sigma Chemical Co (St Louis, USA); BAPTA/AM, Ro-31-8220, calphostin C, and W-7 were products of Calbiochem-Novabiochem International (San Diego, USA). BE2254 {[2-β(4-hydroxyphenyl)-ethylaminomethyl]-tetralone} was from Beiersdorf Co (Hamburg, Germany); [ 3 H]adenine was from Amersham Biosciences (Piscataway, United States); 2,5-diphenyl-oxazole (PPO) was bought from Farco-Pharma (Koln, Germany); fetal bovine serum (FBS) and Dulbecco's Modified Eagle's Medium (DMEM) were from Hyclone China (Beijing, China); HEK293 (human embryonic kidney 293) cells and full-length cDNA of hamster α 1B -AR (pREP4) were kindly provided by Prof Kenneth P MINNEMAN (Emory University, USA).
Transfection of HEK293 cells with cDNA encoding α 1B -AR using the calcium phosphate precipitation method HEK293 cells were cultured in DMEM containing 10% FBS at 5% CO 2 at 37 ºC. The cells were transfected with pREP4/ α 1B -AR by calcium phosphate precipitation at 70% confluence and selected with hygromycin B (0.05 g/L). Three days later the cells were diluted and planted in a 96-well dish, with 0-5 cells in each well. After 2 to 3 cloning sessions, a cell line stably expressing α 1B -AR was obtained. The cells were continuously cultured and kept in DMEM containing selective antibiotics.
Determination of α 1B -AR expression by a saturation radioligand binding assay The cells were grown in 75-mL flasks and harvested in PBS. After centrifugation at 3000×g, 4ºC for 10 min then at 21 000×g, 4ºC, for 20 min, the pellet was resuspended with 30 mL PBS and kept on ice. The ligand-binding properties of the receptors were determined in a series of radioligand binding studies using the α 1 -AR antagonist radioligand [ 125 I]BE2254, which was radioiodinated to theoretical specific activity as described by Engel and Hoyer [19] . Saturation reactions (total volume 250 µL) containing 100 µL or 50 µL PBS with 1% bovine serum albumin (BSA), 50 µL of [ 125 I] BE2254 at different concentrations (15 000-500 000), and 100 µL cell membranes. Nonspecific binding was determined in the presence of 50 µmol/L phentolamine. Reactions were allowed to proceed for 20 min at 37 ºC. Reactions were terminated by adding 7 mL ice-cold Tris-HCl buffer (pH 7.4) and the mixture was filtered onto glass fiber filters. Filters were washed twice with 7 mL ice-cold Tris-HCl buffer and then dried. Bound radioactivity was measured using an auto-gamma counter.
Binding data were analyzed by using nonlinear regression and Scatchard analysis (GraphPad Prizm Software) on a computer and thus the dissociation constant (K D ) between the receptor and antagonist and maximal bound capacity (B max ) could be obtained. Protein content was determined by using the Coomassie protein quantitation method.
cAMP determination in intact cells using ion-exchange chromatography HEK293 cells expressing α 1B -AR were cultured in 24-well dishes at 37 ºC, 5% CO 2 , with 2.5×10 5 cells per mL medium. When the cells were fully confluent, the medium was changed, and [ 3 H]adenine 18.5 MBq (0.5 mCi) was added into each well. After incorporation for 4 h at 37 ºC in 5% CO 2 , the medium was discarded and the cells were washed twice with pre-warmed Krebs' solution. After addition of antagonists in 1 mL Krebs' solution containing 200 µmol/L IBMX and incubation for 30 min, the cells were incubated for a further 20 min with different concentrations of agonists. The reaction was terminated by adding 100 µL of 77% trichloracetic acid, followed by a centrifugation at 3000×g, 4 ºC, for 20 min. Then 50 µL supernatant was transferred into 3 mL scintillation liquid to measure radioactivity as total activity (cpm). The remaining supernatant was applied to Dowex columns and aluminal columns. After being washed with distilled water, the aluminal columns were eluted with 2 mL Tris-HCl (pH 8.0), and the radioactivities of the eluates were measured as newlyproduced cAMP. cAMP accumulation is equal to proportion of total radioactivity represented by newly-produced cAMP as a percentage. The formula is as follows: Twenty-two is the volume constant. Statistical analysis Results are expressed as mean±SD. To compare mean values between two groups, Student's ttest was used; ANOVA was used for comparison among three or more groups. P<0.05 was considered statistically significant.
Results
Density of α 1B -AR HEK293 cells transfected with α 1B -AR were cultured under selective pressure from hygromycin B for several passages, thus we obtained a cell line stably expressing α 1B -AR. The density of α 1B -AR was 2004±138 pmol/g as determined by a radioligand binding assay (n=5, data not shown).
cAMP accumulation induced by stimulation of α 1B -AR In blank HEK293 cells , NE (100 nmol/L-30 µmol/L), cAMP accumulation = Radioactivity of newly-produced cAMP (cpm) ×100 % Total radioactivity (cpm)×22
PE (100 nmol/L-300 µmol/L), or ME (1 µmol/L-1 mmol/L) did not cause cAMP accumulation in the presence of propranolol, an antagonist of β-AR (data not shown). However, NE, PE, and ME all increased cAMP accumulation in HEK293 cells transfected with α 1B -AR in a dosedependent manner, with R max /pD 2 of (3.32%± 0.34%)/ (6.15±0.33) (n=7), (2.43%±0.46%)/(5.37±0.55) (n=8), and (0.66%±0.17%)/(3.79±0.39) (n=6), respectively (Figure 1 ), all of which were antagonized by prazosin (100 nmol/L) (Data not shown).
PLC-PKC pathway
In the presence of propranolol (10 µmol/L) to block β 2 -AR in HEK293 cells, NE (10 µmol/L) increased cAMP accumulation from a basal level of 0.28%± 0.07% to 4.93%±1.13% (n=11, P<0.01). The PLC inhibitor, U73122, had no effect on the NE-induced cAMP accumulation at 1 µmol/L (4.91%±1.43%, n=11) or 10 µmol/L (4.97%±1.15%, n=11, Fig 2A) for 1 h incubation. Neither U73122 itself (0.26%±0.09%, n=5) nor the vehicle alone (Me 2 SO, 0.1% v/v final, 0.26%±0.05%, n=3) affected the basal level of cAMP (0.28%±0.07%, n=11). Similarly, when PKC inhibitors were added, neither Ro31-8220 (5.37%± 1.33%) and (4.99%±1.56%, n=8) nor calphostin C (5.14%± 1.09%) and 4.70%±1.28%, n=8) at 10 nmol/L and 100 nmol/L affected NE-induced cAMP production (4.93%± 1.13%, n=11, Figure 2B ). The two inhibitors had no effect on the basal cAMP level (0.24%±0.07%, n=5, and 0.22%± 0.09%, n=5, respectively, vs 0.28%±0.07%, n=11). To further clarify the role of PKC in this response, we examined whether PKC activator had any effect on cAMP synthesis. Without any AR agonist or antagonist, pretreatment with 1, 10, and 100 nmol/L PMA did not increase cAMP synthesis, the levels of which were (0.23%±0.03%, n=7), (0.22%± 0.08%, n=7), and (0.24%±0.08%, n=7), respectively, showing no significant difference compared with the basal level (0.28%±0.07%, n=11).
Tyrosine kinase signaling pathway The effects of two kinds of tyrosine kinase inhibitors, tyrphostin A25 and genistein, on NE-induced cAMP synthesis were examined. Tyrphostin A25 and genistein (0.30%±0.07% and 0.30%± 0.04%, n=5, respectively) or the vehicle alone (Me 2 SO, 0.1% v/v final, 0.26%±0.03%, n=3) had no effect on the basal cAMP level (0.28%± 0.07%, n=11). After pretreating cells with tyrphostin A25 or genistein at 1 µmol/L and 10 µmol/L for 1 h, neither tyrphostin A25 (4.98%±1.33% and 4.75%± 1.07% at the two concentrations, respectively, n=7) nor genistein (4.97%±1.30% and 4.69%±0.62%, respectively, 
Regulation of cAMP response by G proteins
After incubating cells with PTX 500 µg/L for 16 h, the effects of PTX on basal or NE-induced cAMP accumulation were examined. The results showed that PTX neither had any effect on basal cAMP (0.31%±0.07% vs 0.23%±0.07%, n=8) nor affected the NE-induced cAMP response (1.76%±0.50% vs 1.52%±0.44%, n=8, Figure 4) . In order to examine whether α 1 -AR mediates cAMP response by directly coupling with the G s protein, we compared cAMP accumulation upon stimulation of the G s protein after incubation with 500 µg/L CTX for 3 h with NE-induced cAMP accumulation.
The results showed that cAMP accumulation induced by CTX alone was significantly higher than that induced by 10 µmol/L NE (2.50%±0.60% vs 1.52%±0.44%, n=8, P<0.05), and when CTX and NE were used simultaneously, cAMP accumulation (5.24%±1.37%, n=8) was significantly higher than their combined effect when used alone (P<0.05, Figure 4) .
Regulating effects of Ca 2+ signaling system Because α 1 -AR can induce the release of the IP 3 -sensitive Ca 2+ store, CPA, a Ca 2+ -ATPase inhibitor, was used to block Ca 2+ being taken in sarcoplasmic reticulum again so as to increase [Ca 2+ ] i and deplete the Ca 2+ store. The results showed that CPA 10 µmol/L alone did not increase cAMP accumulation (0.20%±0.03% vs 0.22%±0.12%, n=8), neither did it have any effect on NE-induced cAMP production (1.63%±0.56%, n=8 vs 1.59%±0.47%, n=9, Figure 5A ).
In addition, the influence of the Ca 2+ influx on cAMP synthesis was studied. It was found that NE-induced cAMP accumulation under Ca 2+ -free condition was equal to that when Ca 2+ was present (1.63%± 0.40% vs 1.59%±0.47%, n=9). However, when an extracellular Ca 2+ chelator, EGTA (50 µmol/L), was added in Ca 2+ -free Krebs buffer to pretreat the cells for 1 h, the NE-induced cAMP synthesis was obviously reduced (1.00%±0.31%, n=9, P<0.05, Figure 5B ), whereas 10 µmol/L intracellular Ca 2+ chelator, BAPTA/AM, had no effect on the NE-induced cAMP response under Ca 2+ -free conditions (1.62%±0.58% vs 1.59±0.47%, n=9). There was no further inhibition on cAMP synthesis when BAPTA was used in combination with EGTA (1.03%±0.28% vs 1.00%±0.31%, n=9, Figure 5B ).
To find out what type of Ca 2+ channel admitted Ca
2+
, we examined the effects of two kinds of Ca 2+ channel blockers on cAMP response and found that nifedipine 10 µmol/L (Ltype Ca 2+ channel blocker) did not affect the NE-induced cAMP synthesis (1.47%±0.38% vs 1.59%±0.47%,n=9), whereas CdCl 2 1 mmol/L (nonselective Ca 2+ channel blocker) obviously reduced NE-induced cAMP accumulation (from 1.59%±0.47% to 0.78%±0.23%, n=9, P<0.05, Figure 5C ). Moreover, when pretreating cells with W-7, a calmodulin (CaM) inhibitor, NE-induced cAMP synthesis decreased markedly (0.90%± 0.40%, n=8, P<0.05, Figure 5C ), and the extent of decrease was similar to that induced by EGTA or CdCl 2 (P>0.05), while neither of them had any effect on the basal cAMP level. 
Discussion
Several studies have demonstrated that α 1B -AR mediates the cAMP response in HEK293 cells. However, the signaling pathway through which α 1 -AR mediates the cAMP response is unknown. Many studies have indicated that besides its classical signaling pathway, α 1 -AR can stimulate many other signal transduction pathways as well, such as the tyrosine kinase pathway [15] [16] [17] [18] , the phospholipase A 2 -arachidonic acid (PLA 2 -AA) signaling system [20] , etc. Moreover, α 1 -AR also associates with other signaling pathways through its classical signal transduction pathway and consequently produces cross-talk. cAMP is a second messenger, a product of ATP catalyzed by adenylyl cyclase (AC), and a substrate of phosphodiesterase (PDE). There are at least 10 isozymes of AC. Besides the G s and G i proteins, many factors have been found to regulate their activities [21, 22] . In the present study, we investigated the underlying mechanism involved in α 1 -AR-mediated cAMP synthesis using HEK293 cells transfected with α 1B -AR.
PLC-PKC pathway α 1 -AR preferentially activates its classical signaling pathway. It stimulates PLC by coupling with the G q/11 protein, then PLC hydrolyzes PIP 2 to produce IP 3 and DAG, which induces Ca 2+ release and stimulates PKC, thereby producing biological effects. It has been reported that in some cell lines transfected with α 1 -AR subtypes, α 1 -AR first stimulates PI turnover to activate PKC, and then stimulates AC. This means that α 1 -AR-mediated cAMP response is secondary to the PLC-PKC pathway [10] [11] [12] . However, our results indicated that neither the PLC antagonist, U73122, nor the PKC antagonists, Ro31 and calphostin C, inhibited α 1 -AR-mediated cAMP synthesis, and the PKC activator, PMA, did not in crease cAMP accumulation. Furthermore, there was no influence on cAMP synthesis when using the Ca 2+ -ATPase inhibitor, CPA, to block Ca 2+ restoration and thus deplete the Ca 2+ pool. All of the above suggests the taches lying in downstream of PLC in the classical pathway are not connected with α 1 -AR-mediated cAMP response.
Tyrosine kinase signal transduction pathway The tyrosine kinase signal transduction pathway relates closely to the classical signaling pathway of α 1 -AR. Some studies have shown that tyrosine kinase probably participates in α 1 -AR-mediated biological effects [15] [16] [17] [18] . In our previous study, we found that the major functional α 1 -AR subtype of the vascular bed in rat hind legs was α 1A -AR, and that tyrosine kinase antagonists could dose-dependently reduce the vascular contractive response to NE. Moreover, tyrosine kinase antagonists can inhibit α 1 -AR-mediated increase in intracellular Ca 2+ in HEK293 cells [23] , showing that α 1 -AR can activate tyrosine kinase. It is also known that tyrosine kinase can indirectly stimulate AC through the PLC-γ-IP 3 / DAG pathway, which results in intracellular Ca 2+ mobilization and stimulation of PKC [22] . Since we have confirmed that α 1 -AR does not mediate cAMP synthesis through the PLC-PKC pathway in HEK293 cells, the possibility mentioned above can be excluded. Although it is known that tyrosine kinase can indirectly stimulate AC through the PLC-γ-IP 3 /DAG pathway [21] , this would not happen in HEK293 cells because our study indicated that the PLC-PKC pathway was not involved in α 1 -AR-mediated cAMP accumulation. However, whether tyorsine kinase plays a role through other pathways or taches is unclear. In our present study, two kinds of tyrosine kinase inhibitors, different in structure and mechanism, exerted no influence on NE-induced cAMP synthesis, suggesting that tyrosine kinase is not involved in α 1B -AR-mediated cAMP response in HEK293 cells.
Regulation of cAMP response by G proteins α 1 -AR is a typical G protein coupled receptor, whose classical signaling pathway is to couple with the G q/11 protein. But it has been found that α 1 -AR also couples with G s and G i proteins [14, 24] . Overexpressed α 1 -AR in the heart of transgenic mice can couple with the G i protein and inhibit AC [24] . Horie et al [14] found that stimulation of transfected α 1 -AR directly activated G s and increased cAMP accumulation. These phenomena occur when the density of α 1 -AR is much higher than normal. Some researchers [14, 25] consider that receptor-G promiscuity happens when receptors are overexpressed, ie, receptors not only couple with their traditional G proteins, but also couple with irrelevant G proteins under normal conditions, and then produce new biological effects. This phenomenon is called receptor-G protein promiscuity, which would occur when receptors are overexpressed [14, 25] . Since our experiments were performed under similar conditions, this leads to the following question: did promiscuity occur between α 1 -AR and other G proteins? Firstly, the results showed α 1B -AR-mediated cAMP response was not affected by PTX, thereby excluding the possibility that G i protein or G βγ , which is sensitive to PTX [27] and activates ACII and IV [21, 22, 28] , which is involved in the response. Secondly, cAMP accumulation induced by CTX alone was markedly higher than that induced by NE, and when CTX and NE worked together cAMP accumulation was far higher than the sum of cAMP accumulation when each of them worked alone. The response induced by NE 10 µmol/L almost reached a maximum, and since there is no receptor reserve in cloned HEK293 cells [25] , if α 1B -AR directly coupled with the G s protein while the number of G s were relatively insufficient or equally by the number of α 1B -AR, cAMP accumulation induced by NE should equal that induced by CTX, and should not increase further when NE was added together with CTX. However, it did not occur. Thus there are two possibilities, one is that α 1B -AR directly couples with the G s protein but that the amount of G s protein far exceeds what α 1B -AR requires; another is that α 1B -AR itself does not couple with the G s protein, which is more likely, because in our study, stimulation of α 1B -AR and the G s protein at the same time induced a synergistic effect. In addition, the G α , G βγ subunit should not be ignored, because it has been shown to activate ACII and IV [21, 22, 28] . However, because G βγ is PTXsensitive [27] , and PTX did not inhibit NE-induced cAMP sythesis in our study, we conclude that G βγ does not participate in the response.
Regulating effects of Ca 2+ signaling system α 1 -AR can induce the mobilization of intracellular Ca 2+ as well as the influx of extracellular Ca
2+
. As the most ubiquitous and most active second messenger in cells, Ca 2+ not only mediates many physiological effects directly, but also regulates many signaling pathways and molecules. It has been shown that the Ca 2+ -CaM complex can stimulate ACI, III, and VIII [21, 22] . [29] , and in our study, the Ltype Ca 2+ channel inhibitor nifedipine did not affect NEinduced cAMP sythesis. The nonselective Ca 2+ channel inhibitor CdCl 2 obviously reduced NE-induced cAMP accumulation, and the extent of reduction was the same as that with EGTA. If these facts are taken together with the fact that CPA-induced Ca 2+ store depletion did not increase cAMP accumulation, it seems that it was via receptor-dependent Ca 2+ channels that extracellular Ca 2+ entered the cells. CaM inhibitor W-7 significantly reduced NE-induced cAMP accumulation, with the extent of reduction almost equal to that induced by EGTA and CdCl 2 , which indicates that it is Ca 2+ -CaM that activates AC. Intracellular Ca 2+ chelator BAPTA can chelate Ca 2+ released from the Ca 2+ store as well as Ca 2+ entering cells from the outside, so theoretically it should have an effect similar to EGTA. In fact, it neither inhibited NE-induced cAMP synthesis nor enhanced the inhibitory effect of EGTA. As for the reason why intracellular Ca 2+ chelator BAPTA could not inhibit NE-induced cAMP synthesis, we suppose either that the penetrability of BAPTA/ AM into HEK293 cells was rather weak, or that the activity of esterase in HEK293 cells is so low that BAPTA/AM cannot be degraded to active BAPTA. Furthermore, our previous study showed that [Ca 2+ ] i increased to 4-5 times the basal level 8 s after activation of α 1 -AR. Active BAPTA was perhaps not enough to chelate all intracellular Ca 2+ completely and rapidly, so BAPTA/AM had little effect. However, the exact mechanism by which the system functions remains to be studied. In summary, the results suggest that stimulation of α 1B -AR triggers the receptor-dependent Ca 2+ channel via an unknown pathway and lets extracellular Ca 2+ in, then Ca 2+ links CaM into a Ca 2+ -CaM complex, which activates AC to increase cAMP synthesis. However none of EGTA, CdCl 2 , and W-7 are able to completely inhibit NE-induced cAMP accumulation, suggesting that the Ca 2+ influx is only partly involved in the response.
In conclusion, by coupling with a PTX-insensitive G protein, α 1B -AR promotes Ca 2+ influx via receptor-dependent Ca 2+ channels, then Ca 2+ links to CaM to form a Ca 2+ -CaM complex, which stimulates adenylyl cyclase (AC) and thereby increases the cAMP production in HEK293 cell lines. But Ca 2+ only partly contributes to α 1B -AR-mediated cAMP accumulation. The other mechanisms remain to be investigated.
